AI Adoption Key to Boosting UK Competitiveness, Not Job Losses
AI Misconceptions Debunked: UK Businesses Urged to Embrace AI to Stay Competitive Reveals White Paper from Automated Analytics DONCASTER, England, Sept. 9, 2024 /PRNewswire/ — A groundbreaking new white paper from British AI software leader Automated Analytics challenges the widespread fear t
Yadea Showcases Advanced Electric Two-Wheelers at IFA Berlin 2024, Leading the Way in Sustainable Mobility
BERLIN, Sept. 9, 2024 /PRNewswire/ — The Internationale Funkausstellung Berlin (IFA), the top-tier international tech fair, opened in Berlin, Germany from September 6th to 10th. Coinciding with the 100th anniversary of IFA, Yadea, the world’s largest electric two-wheeler brand, makes an
Yadea Showcases Advanced Electric Two-Wheelers at IFA Berlin 2024, Leading the Way in Sustainable Mobility
BERLIN, Sept. 9, 2024 /PRNewswire/ — The Internationale Funkausstellung Berlin (IFA), the top-tier international tech fair, opened in Berlin, Germany from September 6th to 10th. Coinciding with the 100th anniversary of IFA, Yadea, the world’s largest electric two-wheeler brand, makes an
Repurchase of Truecaller B shares in week 36, 2024
STOCKHOLM, Sept. 9, 2024 /PRNewswire/ — During 2 September 2024 and 6 September 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 490,000 own B shares (ISIN: SE0016787071), corresponding to 0.14% of outstanding capital, as part of the share buyback programme i
Repurchase of Truecaller B shares in week 36, 2024
STOCKHOLM, Sept. 9, 2024 /PRNewswire/ — During 2 September 2024 and 6 September 2024 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 490,000 own B shares (ISIN: SE0016787071), corresponding to 0.14% of outstanding capital, as part of the share buyback programme i
Diamyd Medical to pursue accelerated approval pathway for Type 1 Diabetes precision medicine
STOCKHOLM, Sept. 9, 2024 /PRNewswire/ — Diamyd Medical will pursue an accelerated approval pathway in the U.S. for its antigen-specific immunotherapy, Diamyd® (rhGAD65/alum), aimed at preserving endogenous insulin production in patients with Stage 3 Type 1 Diabetes. An earlier interim study r
Diamyd Medical to pursue accelerated approval pathway for Type 1 Diabetes precision medicine
STOCKHOLM, Sept. 9, 2024 /PRNewswire/ — Diamyd Medical will pursue an accelerated approval pathway in the U.S. for its antigen-specific immunotherapy, Diamyd® (rhGAD65/alum), aimed at preserving endogenous insulin production in patients with Stage 3 Type 1 Diabetes. An earlier interim study r
Ping An Selected for Hang Seng Corporate Sustainability Index. Series for 14th Consecutive Year
HONG KONG and SHANGHAI, Sept. 9, 2024 /PRNewswire/ — Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An“, the “Company” or the “Group”, HKEX: 2318 / 82318; SSE: 601318) has been included as a constituent member in the Hang Seng Corporate
Ping An Selected for Hang Seng Corporate Sustainability Index. Series for 14th Consecutive Year
HONG KONG and SHANGHAI, Sept. 9, 2024 /PRNewswire/ — Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An“, the “Company” or the “Group”, HKEX: 2318 / 82318; SSE: 601318) has been included as a constituent member in the Hang Seng Corporate
Experience the Future of Smart Living with Hisense at IFA 2024
QINGDAO, China, Sept. 9, 2024 /PRNewswire/ — Hisense, a global leader in home appliances and consumer electronics, unveiled its innovative smart home solutions at IFA 2024. Based on the theme “The Scenario-driven Future of Tech,” Hisense showcased its latest smart home appliances a
